Paper41596149
Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine.
Afşin Y and 4 others. Antioxidants (Basel), 2026. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine. Papers, record 41596149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596149
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28698459 | Dietary Natural Products for Prevention and Treatment of Breast Cancer. | Nutrients | 2017 | https://conductscience.org/library/papers/28698459 | PubMed |
| 2 | 33533291 | Thymoquinone Potentiated the Anticancer Effect of Cisplatin on Hepatic Tumorigenesis by Modulating Tissue Oxidative Stress and Endoplasmic GRP78/CHOP Signaling. | Nutr Cancer | 2022 | https://conductscience.org/library/papers/33533291 | PubMed |
| 3 | 39061847 | The Cancer Antioxidant Regulation System in Therapeutic Resistance. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39061847 | PubMed |
| 4 | 32282368 | Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells. | Anticancer Drugs | 2020 | https://conductscience.org/library/papers/32282368 | PubMed |
| 5 | 6382953 | Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. | Adv Enzyme Regul | 1984 | https://conductscience.org/library/papers/6382953 | PubMed |
| 6 | 20370557 | Reactive oxygen species in cancer. | Free Radic Res | 2010 | https://conductscience.org/library/papers/20370557 | PubMed |
| 7 | 40284530 | Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284530 | PubMed |
| 8 | 33052979 | Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1. | PLoS One | 2020 | https://conductscience.org/library/papers/33052979 | PubMed |
| 9 | 36769274 | Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769274 | PubMed |
| 10 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 11 | 32908926 | Quercetin Downregulates Cyclooxygenase-2 Expression and HIF-1α/VEGF Signaling-Related Angiogenesis in a Mouse Model of Abdominal Aortic Aneurysm. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32908926 | PubMed |
| 12 | 12001989 | Death and anti-death: tumour resistance to apoptosis. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/12001989 | PubMed |
| 13 | 21856292 | The flavonoid quercetin in disease prevention and therapy: facts and fancies. | Biochem Pharmacol | 2012 | https://conductscience.org/library/papers/21856292 | PubMed |
| 14 | 33004940 | Integrated transcriptomic and metabolomic data reveal the flavonoid biosynthesis metabolic pathway in Perilla frutescens (L.) leaves. | Sci Rep | 2020 | https://conductscience.org/library/papers/33004940 | PubMed |
| 15 | 37810967 | Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. | Front Oncol | 2023 | https://conductscience.org/library/papers/37810967 | PubMed |
| 16 | 23076131 | Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology. | Cell Adh Migr | 2012 | https://conductscience.org/library/papers/23076131 | PubMed |
| 17 | 26579469 | HIF-1α pathway: role, regulation and intervention for cancer therapy. | Acta Pharm Sin B | 2015 | https://conductscience.org/library/papers/26579469 | PubMed |
| 18 | 22304911 | Hypoxia-inducible factors in physiology and medicine. | Cell | 2012 | https://conductscience.org/library/papers/22304911 | PubMed |
| 19 | 18655183 | Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. | J Cell Biochem | 2008 | https://conductscience.org/library/papers/18655183 | PubMed |
| 20 | 30106145 | PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review). | Mol Med Rep | 2018 | https://conductscience.org/library/papers/30106145 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42732404 | cRGD-Targeted Nanoparticles Co-Loaded with Ag, Quercetin and PD-L1 siRNA with Combined Antibacterial and Immunotherapeutic Functions Against Fusobacterium nucleatum-Associated Triple-Negative Breast Cancer. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42732404 | PubMed |
| 42351676 | Synergistic Effects of Doxorubicin and Quercetin on ROS-Associated Apoptosis and EGFR/FOXP3 Modulation in OVCAR3 Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351676 | PubMed |
| 42255707 | Pharmacological and Phytochemical Insights Into Ficus benghalensis (Indian Banyan): Anti-Inflammatory, Antioxidant, and Anticancer Potentials. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42255707 | PubMed |
| 42137366 | Advancing the frontiers of phytotherapy: a comprehensive review of botanical interventions targeting mitochondrial quality control to ameliorate endometriosis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42137366 | PubMed |
| 42075801 | Quercetin Sensitizes Retinoblastoma Cells to Mitomycin C Through Transcriptional Modulation of p53-Regulated Apoptotic Genes: A Preclinical Study. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075801 | PubMed |
| 42072718 | Quercetin Enhances Topotecan Cytotoxicity in Retinoblastoma Cells Through ROS-Associated Stress and Apoptotic Signaling. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072718 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| PTK2B | 2185 | PubTator's text mining | https://conductscience.org/library/genes/2185 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41596149
GET https://conductscience.org/api/papers/v1/41596149/references?page=2